Efficacy and Safety of AQX-1125 in IC/BPS

NCT01882543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Cystitis
Bladder Pain Syndrome

Interventions

DRUG: AQX-1125
DRUG: Placebo

Sponsor

Aquinox Pharmaceuticals (Canada) Inc.